A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the safety and antihypertensive efficacy of
MK-0954A (Losartan 50 mg / Hydrochlorothiazide (HCTZ) 12.5 mg) in participants with mild to
moderate essential hypertension.